NCT04834908View on ClinicalTrials.gov

Evaluation of Equine Antibody Treatment in Patients With COVID 19 Infection

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

July 27, 2021

Primary Completion Date

May 25, 2022

Study Completion Date

May 25, 2022

Conditions
SARS-CoV-2 Infection
Interventions
BIOLOGICAL

Equine COVID-19 Antiserum

Equine COVID-19 antiserum is a polyclonal antibody and it contains Equine COVID-19 immune globulin G.

DRUG

Standard of care

Standard of care for COVID 19 infection based on the current guidelines and institutional practice will be provided

Trial Locations (1)

411001

Jehangir Hospital, Pune

Sponsors
All Listed Sponsors
lead

Bharat Serums and Vaccines Limited

INDUSTRY